Quantum-Si Incorporated (NASDAQ:QSI) stock surged more than 24% on Tuesday after the company presented interim Proteus data at HUPO 2026.
Quantum-Si Highlights Proteus Performance
The protein analysis company described the results as a “step-change” in performance for its Proteus platform.
In a control peptide study, Proteus delivered a median of 30 times more alignments than Platinum Pro from a single chamber.
Proteus also identified all six control peptides in every run. Its median false discovery rate was 1.36%, compared with 6.58% for Platinum Pro.
Based on the single-chamber results, Quantum-Si projects that a full four-chamber Proteus run could generate about 60 times more alignments than a two-chamber Platinum Pro run.
In protein mixtures prepared with a commercial library preparation kit, Proteus identified 1.6 to 2.0 times more peptides than Platinum Pro.
Proteus also detected all 24 proteins in a separate panel that had not previously been sequenced on either platform. Platinum Pro detected an average of 20.3.
The platform detected 4.3 times more amino acids per run. Quantum-Si also reported higher per-residue detection, including for cysteine and histidine, which were detected only on Proteus.
See More: Top Growth Stocks
Trading Volume Surges
Trading activity was unusually heavy Tuesday. QSI’s session volume reached 20.54 million shares, compared with its 100-day average volume of 2.85 million shares.
That means roughly seven times the stock’s normal daily volume had changed hands.
The elevated activity is notable because Quantum-Si is a micro-cap stock, a category that can experience sharp price swings when trading volume accelerates.
QSI Price Action: Quantum-Si shares were up 24.39% at $0.98 at the time of publication on Tuesday, according to Benzinga Pro data.
Image via Shutterstock
Login to comment